Investor Presentation
September 2020
DISCLAIMERS AND FORWARD-LOOKING STATEMENTS
Statements we make in this presentation may include statements which are not historical facts and are considered forward-looking within the meaning of
Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "seeks," "should," "will," "could," "appears," "shall," "target," "contemplated,"
"predicts," "potential," "continue" and variations and negatives of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved.
Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation, statements about our future financial performance and ability to achieve profitability, including our revenue, costs of revenue and operating expenses; our anticipated growth and growth strategies and our ability to effectively manage that growth; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to maintain the security and availability of our platform; our predictions about our industry (including total addressable market) and market trends for healthcare technology solutions; our ability to attract, retain and cross-sell to healthcare provider clients; our ability to maintain renewal rates for healthcare provider clients; our ability to maintain, protect and enhance our intellectual property; our ability to comply with modified or new laws and regulations applying to our business; the increased expenses associated with being a public company; and our outstanding debt under our credit facility, as well as those set forth in our Annual Report on Form 10-K that was filed with the SEC on
April 23, 2020 and our other filings with the U.S. Securities and Exchange Commission, including "Risk Factors" sections contained therein.
We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. This presentation also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates.
This presentation may include certain non-GAAP financial measures as defined by SEC rules. We have provided a reconciliation of those measures to the most directly comparable GAAP measures, which is available in the Appendix.
2
is Patient Intake
Who we are: Leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care
What we do: Enable healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care
How we do it: Software-as-a-Service (SaaS) platform to manage the patient intake process and an integrated patient payments solution for secure processing of patient payments
~1,600 healthcare provider organizations
$1.9B
patient payments processed in FY20
$125M
revenue in FY20
25% revenue growth in FY20
~$7B total addressable market
3
INVESTMENT HIGHLIGHTS
Leadership in large, underpenetrated and growing market with strong tailwinds
Leading SaaS platform for patient intake and experience with integrated patient payments
Significant and measurable return on investment
Proven ability to innovate and meet the evolving needs of our clients
Attractive, highly scalable financial model
Multiple growth opportunities
Founder-led and deeply experienced management team with strong culture
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Phreesia Inc. published this content on 08 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2020 20:24:02 UTC